These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2900488

  • 21. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
    Soussy CJ, Le Van Thoi J, Duval JR.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
    [Abstract] [Full Text] [Related]

  • 22. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
    Soussy CJ, Le Van Thoi J, Meyran M, Joly B, Derlot E, Morel C.
    Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
    [Abstract] [Full Text] [Related]

  • 23. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
    Duval J, Deforges L, Bergogne-Berezin E, Chabbert YA, Courtieu AL, Cluzel R, Dabernat H, Witchitz JL.
    Sem Hop; 1983 Jun 30; 59(26):1949-52. PubMed ID: 6310784
    [Abstract] [Full Text] [Related]

  • 24. [In vitro antibacterial activity of RU 51746 (sodium salt of cefpodoxime). Results of a multicenter study].
    Soussy CJ, Le Van Thoi J, Kitzis MD, Chanal C, Mounier M, Derlot E, Vergnaud M.
    Pathol Biol (Paris); 1990 May 30; 38(5):336-42. PubMed ID: 2195445
    [Abstract] [Full Text] [Related]

  • 25. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
    Jones RN, Barry AL, Fuchs PC, Thornsberry C.
    J Clin Microbiol; 1986 Aug 30; 24(2):233-9. PubMed ID: 3091634
    [Abstract] [Full Text] [Related]

  • 26. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A, Desnoes M, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1985 May 30; 33(5):313-9. PubMed ID: 3929216
    [Abstract] [Full Text] [Related]

  • 27. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S, Ianniello F, Leone S, Esposito S.
    J Antimicrob Chemother; 2003 Nov 30; 52(5):869-72. PubMed ID: 14519672
    [Abstract] [Full Text] [Related]

  • 28. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M, Cluzel M, Sirot D, Joly B, Sirot J, Cluzel R.
    Pathol Biol (Paris); 1986 May 30; 34(5):385-9. PubMed ID: 3095773
    [Abstract] [Full Text] [Related]

  • 29. In vitro antimicrobial activity and susceptibility testing of ofloxacin. Current status.
    Fuchs PC.
    Am J Med; 1989 Dec 29; 87(6C):10S-13S. PubMed ID: 2690614
    [Abstract] [Full Text] [Related]

  • 30. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
    Rolin O, Bouanchaud DH.
    Pathol Biol (Paris); 1989 May 29; 37(5):375-7. PubMed ID: 2780094
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
    Yu KW, Neu HC.
    Antimicrob Agents Chemother; 1990 Sep 29; 34(9):1839-42. PubMed ID: 2126695
    [Abstract] [Full Text] [Related]

  • 32. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
    Hamilton-Miller JM.
    J Antimicrob Chemother; 1992 Feb 29; 29(2):141-7. PubMed ID: 1506329
    [Abstract] [Full Text] [Related]

  • 33. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L.
    J Antimicrob Chemother; 1987 Nov 29; 20 Suppl B():13-9. PubMed ID: 3429381
    [Abstract] [Full Text] [Related]

  • 34. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
    Maskell JP, Sefton AM, Yong J, Chi SJ, Williams JD.
    Infection; 1988 Nov 29; 16(6):365-70. PubMed ID: 3146552
    [Abstract] [Full Text] [Related]

  • 35. In vitro susceptibility studies with josamycin and erythromycin.
    Strausbaugh LJ, Dilworth JA, Gwaltney JM, Sande MA.
    Antimicrob Agents Chemother; 1976 Mar 29; 9(3):546-8. PubMed ID: 4012
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline].
    Maugein J, Fourche J, Mormede M, Pellegrin JL.
    Pathol Biol (Paris); 1989 Jun 29; 37(5 Pt 2):565-7. PubMed ID: 2797881
    [Abstract] [Full Text] [Related]

  • 39. [In vitro activity of imipenem against hospital bacteria].
    Soussy CJ, Duval J.
    Presse Med; 1990 Apr 04; 19(13):583-7. PubMed ID: 2139936
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.